BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+22.78%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12.2B
AUM Growth
+$12.2B
Cap. Flow
+$1.32B
Cap. Flow %
10.82%
Top 10 Hldgs %
86.71%
Holding
139
New
5
Increased
21
Reduced
9
Closed
18

Top Buys

1
INCY icon
Incyte
INCY
$1.42B
2
AVXS
AveXis, Inc. Common Stock
AVXS
$14M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
$10.9M
4
ASND icon
Ascendis Pharma
ASND
$9.19M
5
NGNE icon
Neurogene
NGNE
$6.64M

Top Sells

1
ABBV icon
AbbVie
ABBV
$106M
2
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
$19.5M
3
ARRY
Array Biopharma Inc
ARRY
$8.94M
4
EXEL icon
Exelixis
EXEL
$8.67M
5
ARAV
Aravive, Inc. Common Stock
ARAV
$5.56M

Sector Composition

1 Healthcare 92.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QLGN icon
101
Qualigen Therapeutics
QLGN
$3.03M
$568K ﹤0.01%
400,000
– –
ADAP
102
Adaptimmune Therapeutics
ADAP
$15.3M
$551K ﹤0.01%
100,000
– –
TARA icon
103
Protara Therapeutics
TARA
$120M
$523K ﹤0.01%
298,591
-90,803
-23% -$159K
BIVV
104
DELISTED
Bioverativ Inc. Common Stock
BIVV
$449K ﹤0.01%
+8,249
New +$449K
DVAX icon
105
Dynavax Technologies
DVAX
$1.19B
$446K ﹤0.01%
75,000
– –
BDSI
106
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$399K ﹤0.01%
210,021
– –
CCXI
107
DELISTED
ChemoCentryx, Inc.
CCXI
$357K ﹤0.01%
49,064
– –
WINT
108
DELISTED
Windtree Therapeutics Inc
WINT
$291K ﹤0.01%
254,973
– –
TMBR
109
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$191K ﹤0.01%
+377,295
New +$191K
CYCCP icon
110
Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock
CYCCP
$691K
$83K ﹤0.01%
13,253
– –
BTX.WS
111
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$12K ﹤0.01%
20,084
– –
ABBV icon
112
AbbVie
ABBV
$374B
– –
-1,685,994
Closed -$106M
ALDX icon
113
Aldeyra Therapeutics
ALDX
$351M
– –
-142,000
Closed -$760K
ALNY icon
114
Alnylam Pharmaceuticals
ALNY
$58.5B
– –
-11,340
Closed -$425K
ARCT icon
115
Arcturus Therapeutics
ARCT
$462M
– –
-2,336,359
Closed -$4.91M
ENTA icon
116
Enanta Pharmaceuticals
ENTA
$180M
– –
-75,357
Closed -$2.52M
IONS icon
117
Ionis Pharmaceuticals
IONS
$9.16B
– –
-57,140
Closed -$2.73M
NERV icon
118
Minerva Neurosciences
NERV
$16.5M
– –
-258,805
Closed -$3.04M
PRQR icon
119
ProQR Therapeutics
PRQR
$237M
– –
-212,698
Closed -$1.04M
QURE icon
120
uniQure
QURE
$896M
– –
-230,000
Closed -$1.29M
SCYX icon
121
SCYNEXIS
SCYX
$34.9M
– –
-467,600
Closed -$1.49M
TENX icon
122
Tenax Therapeutics
TENX
$27.3M
– –
-420,000
Closed -$819K
APTO
123
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-258,311
Closed -$359K
CNCE
124
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-152,964
Closed -$1.57M
SRRA
125
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-200,000
Closed -$298K
2 3 4
5
6